Ethismos Research
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Website
www.ethismos.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ethismos Research
Ethismos Research, Inc. is a clinical stage pharmaceutical company based in Cambridge, Massachusetts, focused on the prevention and treatment of chronic pain and treatment-resistant depression. The company aims to reduce opioid exposure in patients with chronic pain through a novel approach that targets the transition from acute to chronic pain. Ethismos is dedicated to developing safe and effective therapies, leveraging a team with extensive experience in drug development. Their research primarily addresses chronic musculoskeletal low back pain and related substance use disorders.Explore more
Ethismos Research Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ethismos Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Ethismos Research launches new products
Check if Ethismos Research has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Ethismos Research recently announced quarterly report
Funding: Get notified immidiatlly once Ethismos Research has new funding data
Click to see if Ethismos Research had a recent Job posting/layoffs
Check out if Ethismos Research is spiking on competitors!
Website visits: Recent activity has been detected on your website
Ethismos Research, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Ethismos Research
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Ethismos Research
Find more new buyers
Compare Similar Companies to Ethismos Research
Compare insights from companies similar to Ethismos Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ethismos Research is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ethismos Research is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ethismos Research.
Ethismos Research financials insights
Gather financial insights about Ethismos Research, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$50M
Ethismos Research Tech Stack
A closer look at the technologies used by Ethismos Research
Ethismos Research News & Media
Ethismos Research Initiates $50 MM Private Placement Led by VENTURE.co Brokerage Services
CAMBRIDGE, Mass., March 12, 2020 /PRNewswire/ -- Ethismos Research, developing pharmaceutical treatments for chronic pain management, severe depression, and substance use disorders, announced the initiation of a $50 million private placement, led by managing broker-dealer, VENTURE.co...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ethismos Research
Sign Up For FreeTo access detailed company insights
Ethismos Research, Inc. is a clinical stage pharmaceutical company based in Cambridge, Massachusetts, focused on the prevention and treatment of chronic pain and treatment-resistant depression. The company aims to reduce opioid exposure in patients with chronic pain through a novel approach that targets the transition from acute to chronic pain. Et... Read More
